ICON CLINICAL RESEARCH PROPERTY HOLDINGS (IRELAND) LIMITED

Icon Clinical Research Property Holdings (Ireland) Limited is the Irish arm of ICON plc, a global leader in clinical research and development services. The company partners with pharmaceutical, biotech and medical-device sponsors to accelerate the delivery of new therapies, offering a full-service outsourcing model that spans early-phase trials, bioanalytical support, cardiac safety monitoring, and market-access strategy.

Key specialisations include AI-enhanced platforms such as EngageAI, which transforms customer-feedback loops, and bespoke blended solutions that address unique sponsor challenges. ICON's portfolio also covers outcome-measure design, real-world data integration, and tokenisation for vaccine follow-up, alongside dedicated biotech services like due-diligence and asset valuation. Additional capabilities comprise cardiac safety studies (BPM, Holter, ECHO, MUGA), specialty laboratory support for precision-medicine programmes, and comprehensive site-and-patient solutions that prioritise patient-centric recruitment and real-time data capture.

Through regular whitepapers, webinars and industry insights, ICON shares best-practice guidance on topics ranging from AI in software-as-a-medical-device to the implementation of ICH GCP E6(R3). Serving sponsors across Ireland and beyond, the company combines scientific rigour with innovative technology to help bring life-changing treatments to market faster.